Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-01-22FDA Approved: RANOLAZINE — Supplemental Application (Viona Pharmaceuticals Inc)
FDA approved a supplemental application for ranolazine filed by Viona Pharmaceuticals Inc (ANDA 210188). This action completes an additional…
-
FDA approval · 2020-01-06FDA Approved: PROPRANOLOL HYDROCHLORIDE — Original Application (Lannett Company, Inc.)
FDA approved the original application for propranolol hydrochloride from Lannett Company, Inc., enabling a generic version to be marketed.
-
FDA approval · 2019-12-19FDA Approved: CONJUPRI — Original Application (CSPC Ouyi Pharmaceutical Co. Ltd)
FDA approved CONJUPRI (levamlodipine) through an Original Application by CSPC Ouyi Pharmaceutical Co. Ltd for indications including hyperten…
-
FDA approval · 2019-11-21FDA Approved: ATENOLOL — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved atenolol as a generic drug under an Original Application (ANDA) from Unichem Pharmaceuticals (USA), Inc.
-
FDA approval · 2019-11-20FDA Approved: ISOSORBIDE DINITRATE — Original Application (BluePoint Laboratories)
FDA approved the original application for a generic Isosorbide Dinitrate product from BluePoint Laboratories.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-10-31FDA Approved: RANOLAZINE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for ranolazine by Ajanta Pharma USA Inc.
-
FDA approval · 2019-10-30FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for metoprolol tartrate by Hospira, Inc. under ANDA 078085, finalizing changes to the generic produc…
-
FDA approval · 2019-10-24FDA Approved: METOPROLOL — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved Baxter Healthcare Corporation's supplemental application for Metoprolol Tartrate under ANDA 078950. This approval updates a…
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Testosterone Therapy on Angina Threshold and Atheroma in Patients With Chronic Stable Angina [Phase 4]
Phase 4 trial update evaluating testosterone therapy effects on angina threshold and atheroma in patients with chronic stable angina.
-
FDA approval · 2019-10-01FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals Inc)
The FDA approved a supplemental application for Verapamil Hydrochloride by Teva Pharmaceuticals Inc., updating the drug’s labeling and appro…
-
FDA approval · 2019-09-26FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for Verapamil Hydrochloride from Glenmark Pharmaceuticals, updating an already approved generic …
-
FDA approval · 2019-09-25FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for verapamil hydrochloride (generic) from Nivagen Pharmaceuticals, Inc., authorizing the sale o…
-
FDA approval · 2019-09-13FDA Approved: NADOLOL — Original Application (VGYAAN Pharmaceuticals LLC)
The FDA approved Nadolol as a generic product through an Original Application (ANDA) from VGYAAN Pharmaceuticals LLC. Nadolol is a non-selec…
-
CLINICAL_TRIALS trial_result · 2019-08-30Clinical Trial Update: Cell Therapy in Severe Chronic Ischemic Heart Disease [Phase 3]
A Phase 3 trial update for a cell therapy in severe chronic ischemic heart disease has completed.
-
FDA approval · 2019-08-19FDA Approved: RANOLAZINE — Original Application (Viona Pharmaceuticals Inc)
FDA approves a generic version of ranolazine from Viona Pharmaceuticals Inc under an Original ANDA (ANDA210188).
-
FDA label_change · 2019-08-07FDA Approved: BISOPROLOL FUMARATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Bisoprolol Fumarate by Unichem Pharmaceuticals (USA), Inc., resulting in a labeling change for t…
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions [NA]
A completed clinical trial evaluating the safety and effectiveness of the Orsiro sirolimus-eluting coronary stent system in subjects with co…
-
CLINICAL_TRIALS trial_result · 2019-07-22Clinical Trial Update: XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE PRIME SV Japan PMS)
Post-marketing trial update for XIENCE PRIME SV Everolimus-eluting coronary stent in Japan shows completion with results posted.
-
FDA approval · 2019-07-08FDA Approved: KATERZIA — Original Application (Azurity Pharmaceuticals, Inc.)
FDA approves KATERZIA (amlodipine) through an Original Application by Azurity Pharmaceuticals, introducing an amlodipine oral suspension. Th…
-
FDA approval · 2019-07-05FDA Approved: RANOLAZINE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's generic ranolazine for chronic angina as an original ANDA approval.
-
FDA approval · 2019-06-14FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Ingenus Pharmaceuticals, LLC)
The FDA approved Ingenus Pharmaceuticals' generic diltiazem hydrochloride via an original ANDA submission.
-
FDA approval · 2019-06-04FDA Approved: RANOLAZINE — Original Application (Radha Pharmaceuticals, Inc)
FDA approved Radha Pharmaceuticals' original ANDA for ranolazine (generic ranolazine). The approval confirms a generic formulation of ranola…
-
FDA approval · 2019-05-28FDA Approved: RANOLAZINE — Original Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma, Inc.'s original ANDA for ranolazine, a generic oral therapy for chronic angina. This approval makes a gener…
-
FDA approval · 2019-05-28FDA Approved: RANOLAZINE — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s original application for ranolazine, enabling a generic version of the anti-anginal medication.
-
FDA approval · 2019-05-03FDA Approved: METOPROLOL TARTRATE — Supplemental Application (TRUPHARMA LLC)
FDA approved a supplemental application for metoprolol tartrate submitted by TRUPHARMA LLC.